A nursing facility resident with atrial fibrillation is taking digoxin 125 µg daily and has a serum digoxin level of 0.3 ng/mL; can her digoxin dose be increased to improve rate control while awaiting cardiology input?

Can Digoxin Be Increased for Rate Control in This Nursing Facility Resident?

Yes, you can cautiously increase her digoxin dose from 125 mcg to 187.5 mcg or 250 mcg daily, as her current level of 0.3 ng/mL is well below the therapeutic target range of 0.5-0.9 ng/mL, but beta-blockers should be strongly considered as the preferred agent for rate control in atrial fibrillation, with digoxin serving as an adjunctive therapy.

Key Considerations for This Patient

Current Digoxin Level Assessment

Her serum digoxin level of 0.3 ng/mL is substantially subtherapeutic. The ACC/AHA guidelines recommend targeting plasma concentrations of 0.5-0.9 ng/mL 1. At 0.3 ng/mL, she is unlikely to achieve adequate rate control from digoxin alone.

Dose Adjustment Strategy

For a nursing facility resident (likely >70 years old):

• Current dose: 125 mcg daily
• Her low level suggests room for dose escalation
• Recommended approach: Increase to 187.5 mcg daily (1.5 tablets of 125 mcg) or 250 mcg daily 2, 1
• The guidelines specify that doses of 0.125-0.25 mg daily are standard, with low doses (125 mcg) reserved for patients >70 years, impaired renal function, or low lean body mass 1

Critical safety parameters to check before increasing:

• Renal function: Digoxin is primarily renally eliminated; impaired renal function increases toxicity risk 3
• Electrolytes: Hypokalemia and hypomagnesemia dramatically increase digoxin toxicity risk even at therapeutic levels 2, 1, 3
• Thyroid function: Hypothyroidism may reduce digoxin requirements 3
• Concomitant medications: Amiodarone, verapamil, diltiazem, clarithromycin, erythromycin increase digoxin levels 1, 3

The Beta-Blocker Consideration

This is the critical clinical decision point: Guidelines consistently emphasize that beta-blockers are more effective than digoxin for rate control in atrial fibrillation, particularly during exercise 2, 1. The 2013 ACC/AHA guidelines state that "digoxin should be considered as an adjunctive agent for rate control" because beta-blockers improve survival 1.

Before increasing digoxin, assess:

• Is she already on a beta-blocker? If not, why not?
• If she has heart failure with reduced ejection fraction, beta-blockers provide mortality benefit that digoxin does not 1
• If beta-blockers are contraindicated (severe bradycardia, decompensated heart failure, severe COPD), then digoxin becomes more appropriate as primary therapy

Practical Dosing Algorithm

If proceeding with digoxin increase:

1. Verify safety parameters (renal function, electrolytes, drug interactions)
2. For patients >70 years with normal renal function: Increase to 187.5 mcg daily initially
3. For patients <70 years with good renal function: Can increase to 250 mcg daily
4. Recheck digoxin level in 7-10 days (5 half-lives to reach steady state, but elderly may take longer) 3
5. Target level: 0.5-0.9 ng/mL (NOT the older 0.8-2.0 ng/mL range) 1

Important Safety Warnings

Levels >1.0 ng/mL are associated with increased mortality 2, 4. A 2018 study found that patients with levels ≥1.2 ng/mL had a 56% increased hazard of mortality 5. The therapeutic window has narrowed considerably from historical recommendations.

Signs of digoxin toxicity to monitor:

• Cardiac: Bradycardia, heart block, ventricular arrhythmias
• GI: Anorexia, nausea, vomiting
• Neurologic: Visual disturbances (yellow-green halos), confusion, disorientation 1

Toxicity risk factors in elderly nursing home residents:

• Low lean body mass (common in frail elderly)
• Declining renal function
• Polypharmacy with interacting medications
• Electrolyte disturbances from diuretics or poor nutrition 1, 3

The Nursing Facility Context

Given that she doesn't want hospitalization, this makes careful outpatient management essential:

• Ensure facility can monitor heart rate regularly
• Arrange for repeat digoxin level in 1-2 weeks after dose change
• Ensure electrolytes and renal function are monitored
• Consider whether rate control is truly inadequate—what is her current ventricular rate at rest and with activity?

When NOT to Increase Digoxin

Contraindications to dose increase:

• Significant sinus or AV block (unless pacemaker present) 1
• Current bradycardia
• Acute decompensated heart failure (stabilize first) 2
• Severe renal impairment without dose adjustment for CrCl 3

Bottom Line

You can increase her digoxin dose given the subtherapeutic level, but this should be done with careful attention to her age, renal function, and electrolytes. More importantly, reassess whether beta-blocker therapy should be initiated or optimized, as guidelines consistently position digoxin as adjunctive rather than primary therapy for rate control in atrial fibrillation 2, 1. If she has heart failure with reduced ejection fraction, beta-blockers provide mortality benefit that digoxin cannot 1.